Beta
Miglitol
medication Under reviewAn alpha-glucosidase inhibitor medication used to manage blood sugar levels in type 2 diabetes by slowing carbohydrate digestion.
Research summary
Scientific evidence on miglitol primarily derives from clinical trials in Japanese populations with metabolic syndrome, overweight, or type 2 diabetes, showing consistent reductions in body weight, BMI, insulin resistance, and postprandial glucose and insulin levels. These effects are more pronounced with lifestyle interventions, with no severe adverse events reported, though higher-quality, larger, blinded studies in diverse populations are needed for broader consensus. No studies were identified exclusively in healthy human subjects without metabolic conditions, limiting direct applicability to healthy adults. Research consensus supports its role in metabolic health for at-risk groups, with potential anti-obesity benefits through appetite modulation and fat mass reduction.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Miglitol to your stack to report effects
Miglitol treatment improves insulin resistance in patients with metabolic syndrome
Shimabukuro M et al.
Comparison of miglitol with sitagliptin in overweight type 2 diabetes patients
Mikada A et al.
Effects of alpha-glucosidase inhibitors on obesity and diabetes
Sugihara Y et al.
No reports yet
Be the first to report this effect and help the community.
Add Miglitol to your stack to report effects
Miglitol treatment improves insulin resistance in patients with metabolic syndrome
Shimabukuro M et al.
Comparison of miglitol with sitagliptin in overweight type 2 diabetes patients
Mikada A et al.
Effects of alpha-glucosidase inhibitors on obesity and diabetes
Sugihara Y et al.
No reports yet
Be the first to report this effect and help the community.
Add Miglitol to your stack to report effects
Miglitol treatment improves insulin resistance in patients with metabolic syndrome
Shimabukuro M et al.
Comparison of miglitol with sitagliptin in overweight type 2 diabetes patients
Mikada A et al.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Metabolic disorder characterized by high blood sugar
Comparison of miglitol with sitagliptin in overweight type 2 diabetes patients
Mikada A et al.
Effects of alpha-glucosidase inhibitors on obesity and diabetes
Sugihara Y et al.
Research (3 studies)
Comparison of miglitol with sitagliptin in overweight type 2 diabetes patients
Mikada A et al.
Effects of alpha-glucosidase inhibitors on obesity and diabetes
Sugihara Y et al.
Miglitol treatment improves insulin resistance in patients with metabolic syndrome
Shimabukuro M et al.
Community updates
No updates yet for this supplement.
Be the first to share your experience!